Study finds racial disparities in NYC’s 2022 mpox response | CPT PPP Coverage
Cryptopolytech (CPT) Public Press Pass (PPP)
News of the Day COVERAGE
200000048 – World Newser
•| #World |•| #Online |•| #Media |•| #Outlet |
View more Headlines & Breaking News here, as covered by cryptopolytech.com
Study finds racial disparities in NYC’s 2022 mpox response appeared on gaycitynews.com by Gay City News.
A smaller percentage of Black, Latino and Asian patients in New York City received treatment for mpox (formerly known as monkeypox) compared to white New Yorkers, according to a new study of the NYC Department of Health and Mental Hygiene (DOHMH) published by a Centers for Disease Control (CDC) journal.
Mpox spiked during the summer of 2022, hitting New York City’s LGBTQ community hard, but cases have remained low since last fall, thanks in part to a strong vaccination campaign.
The study, co-authored by Maura Lash, a research scientist at the DOHMH, found that a higher percentage of white individuals diagnosed with mpox (38%) had been treated with the antiviral medication tecovirimat, when compared to Black, Latino and Asian New Yorkers (31%, 31%, and 30%, respectively), even though there were more cases among Black and Latino individuals than white people.
The study looked at the period between May 19–October 29, 2022, when 3,740 people were diagnosed with mpox — most of them men who had sex with men. Of those individuals, a majority identified as Black or Latino (61%) and lived in “medium- or high-poverty neighborhoods” (66%).
The authors note that racial disparities in treatment of mpox are similar to disparities in COVID-19 antivirals and HIV treatment. A 2022 CDC study, for instance, found that 36% and 30% fewer Black and Latino patients, respectively, were treated with the antiviral medication paxlovid compared to white patients.
“Future responses to public health emergencies must prioritize institutional and structural racism mitigation from the outset,” the study reads, “to build more resilient communities and healthcare delivery systems.”
The study also credited the DOHMH with connecting patients to available prescribers and mobilizing safety net hospitals and federally qualified health centers to conduct outreach and assistance to bolster access for underinsured and uninsured individuals.
Overall, though, 32% of New Yorkers with reported mpox were treated with medication, which was 12% greater than the national average.
The DOHMH did not return a request for comment regarding the study’s findings.
FEATURED ‘News of the Day’, as reported by public domain newswires.
View ALL Headlines & Breaking News here.
Source Information (if available)
This article originally appeared on gaycitynews.com by Gay City News – sharing via newswires in the public domain, repeatedly. News articles have become eerily similar to manufacturer descriptions.
We will happily entertain any content removal requests, simply reach out to us. In the interim, please perform due diligence and place any content you deem “privileged” behind a subscription and/or paywall.
CPT (CryptoPolyTech) PPP (Public Press Pass) Coverage features stories and headlines you may not otherwise see due to the manipulation of mass media.
First to share? If share image does not populate, please close the share box & re-open or reload page to load the image, Thanks!